PHARMAI

PharmAI is a spin-out originating from the project 'Redivia', which is funded under the EXIST program by the German Federal Ministry for Economic Affairs and Energy and the European Social Fund... Our disruptive software technology identifies drug candidates based on the geometry of protein binding sites and their drug-target interactions. This method paves new ways to explore the drug-target space at a ground-breaking precision... We invested 500 CPU years of pre-computation to ensure a fast delivery of your results just in a few days. Our efficient algorithms make use of this data resource and run order of magnitudes faster than traditional virtual screening.

Also known as: PharmAI GmbH

Primary location: Dresden Germany